- Series A financing to advance clinical development of lead candidate RLS-1496 into Phase 1 studies this year in chronic atopic dermatitis and chronic psoriasis.
(BUSINESS WIRE)--Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies ta…